Published in Ann Surg on September 01, 2004
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Mod Pathol (2011) 2.08
Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg (2008) 1.85
Fine-needle aspiration of the thyroid: an overview. Cytojournal (2005) 1.29
ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg (2005) 1.27
Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog (2006) 1.17
Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules. Diagn Pathol (2010) 1.15
Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol (2010) 1.14
Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Br J Cancer (2005) 1.07
Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. J Cell Mol Med (2010) 1.01
Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. Proc Natl Acad Sci U S A (2005) 0.98
A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer (2007) 0.95
Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms. World J Surg (2006) 0.95
How to define follicular thyroid carcinoma? Virchows Arch (2006) 0.93
Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy. Virchows Arch (2007) 0.92
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn (2006) 0.88
Proteomic profiling of follicular and papillary thyroid tumors. Eur J Endocrinol (2012) 0.87
Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia. Virchows Arch (2005) 0.85
Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch (2009) 0.83
Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies. Ann Surg Oncol (2011) 0.81
Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid. BMC Genomics (2015) 0.81
Prevalence of c.2268dup and detection of two novel alterations, c.670_672del and c.1186C>T, in the TPO gene in a cohort of Malaysian-Chinese with thyroid dyshormonogenesis. BMJ Open (2015) 0.78
Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules. Thyroid Res (2011) 0.78
Distinguishing molecular markers in thyroid tumors: a tribute to Dr. Orlo Clark. World J Surg (2009) 0.77
Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas. BMC Genomics (2015) 0.77
A score based on microscopic criteria proposed for analysis of papillary carcinoma of the thyroid. Virchows Arch (2008) 0.76
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers. PLoS One (2011) 0.76
Classification of Benign and Malignant Thyroid Nodules Using a Combined Clinical Information and Gene Expression Signatures. PLoS One (2016) 0.75
Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma. Clin Exp Med (2016) 0.75
Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med (1993) 4.09
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science (2000) 3.87
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery (2004) 2.73
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol (2002) 2.25
Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab (1997) 2.25
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid (2004) 1.93
Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer (2000) 1.80
Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg (1996) 1.65
Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol (2002) 1.61
Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer (1998) 1.56
Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer (2002) 1.48
Follicular thyroid carcinoma: histology and prognosis. Cancer (2004) 1.46
Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract (2003) 1.41
Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res (2003) 1.36
The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem (2003) 1.35
Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg (2002) 1.32
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res (2003) 1.31
Adrenomedullin and cancer. Regul Pept (2003) 1.29
Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer (2000) 1.28
Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab (2004) 1.15
Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett (2003) 1.13
Ultrasound-guided fine-needle aspiration of the thyroid assessed by Ultrafast Papanicolaou stain: data from 1135 biopsies with a two- to six-year follow-up. Thyroid (2001) 1.08
Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol (2003) 1.07
The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery (2003) 0.98
Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid. Cancer (1998) 0.95
Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol (1993) 0.94
Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab (2001) 0.91
Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer (2003) 0.91
Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg (2004) 0.88
Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res (2004) 0.88
Long-term follow-up of patients with initially benign thyroid fine-needle aspirations. Thyroid (2001) 0.85
Cytokeratin expression profiles in thyroid carcinomas. Eur J Surg Oncol (2001) 0.84
Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterology (2000) 0.83
Gene expression analysis reveals evidence for inactivation of the TGF-beta signaling cascade in autonomously functioning thyroid nodules. Oncogene (2004) 0.83
Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Cancer Res (2004) 0.82
The cytological and clinical value of the thyroid "follicular lesion". Am J Otolaryngol (2003) 0.82
Telomerase activity in benign and malignant thyroid diseases. Surgery (1997) 0.81
Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol (2003) 0.80
Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents. J Endocrinol Invest (2002) 0.79
Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array. Thyroid (2001) 0.78
Encapsulated cystic papillary variant of medullary carcinoma of thyroid gland. Endocr Pathol (2002) 0.78
Hyalinizing trabecular adenoma of the thyroid. A report of two cases with cytologic, histologic and immunohistochemical findings. Acta Cytol (1997) 0.77
Large-needle aspiration biopsy for the preoperative selection of follicular adenoma diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer. Am J Clin Oncol (2002) 0.77
Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA (2004) 5.44
Effects of limited work hours on surgical training. J Am Coll Surg (2002) 3.82
Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg (2008) 1.85
Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg (2009) 1.62
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol (2008) 1.60
Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Surgery (2011) 1.43
Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res (2003) 1.36
Robotic and endoscopic transaxillary thyroidectomies may be cost prohibitive when compared to standard cervical thyroidectomy: a cost analysis. Surgery (2012) 1.32
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res (2012) 1.28
Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol (2010) 1.26
The use of endoscopic ultrasound in the diagnosis of solid pseudopapillary tumors of the pancreas in children. J Pediatr Surg (2002) 1.21
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid (2009) 1.16
Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab (2004) 1.15
Seminars: local and regional anesthesia for thyroid surgery. J Surg Oncol (2006) 1.10
Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol (2011) 1.09
Substernal thyroidectomy is associated with increased morbidity and mortality as compared with conventional cervical thyroidectomy. J Am Coll Surg (2007) 1.04
Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab (2002) 0.93
Molecular markers in thyroid cancer diagnostics. Surg Clin North Am (2009) 0.92
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis (2003) 0.89
Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery (2008) 0.89
Identification of borderline thyroid tumors by gene expression array analysis. Cancer (2009) 0.89
Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Surgery (2005) 0.88
Adrenocortical carcinoma: the influence of large vessel extension. Surgery (2010) 0.88
Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn (2006) 0.88
Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy. World J Surg (2008) 0.87
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab (2013) 0.87
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing. J Surg Res (2012) 0.86
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leuk Lymphoma (2008) 0.86
Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol (2010) 0.85
Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer (2010) 0.85
Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol (2014) 0.85
Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Ann Surg Oncol (2003) 0.85
Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma. Surgery (2013) 0.84
Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery (2008) 0.84
Sympathetic paraganglioma in a patient with unrepaired tetralogy of Fallot: a case report and review of the literature. J Clin Endocrinol Metab (2012) 0.84
Lymph node dissection in papillary thyroid carcinoma. Semin Nucl Med (2011) 0.84
Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease. J Gastrointest Surg (2013) 0.83
The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol (2008) 0.82
Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations. Expert Rev Mol Diagn (2013) 0.81
Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies. Ann Surg Oncol (2011) 0.81
Molecular analysis of Hurthle cell neoplasms by gene profiling. Surgery (2004) 0.81
Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling. Thyroid (2005) 0.80
Supplemental oxygen and risk of surgical wound infection. JAMA (2006) 0.80
The impact of incidental identification on the stage at presentation of lower gastrointestinal carcinoids. J Am Coll Surg (2011) 0.80
Antisense hTERT inhibits thyroid cancer cell growth. J Clin Endocrinol Metab (2003) 0.79
Serum leptin levels in acute protein deprivation. JPEN J Parenter Enteral Nutr (2003) 0.79
Does bethesda category predict aggressive features in malignant thyroid nodules? Ann Surg Oncol (2013) 0.78
Three-dimensional CT volumetry predicts outcome of laparoscopic splenectomy for splenomegaly: retrospective clinical study. World J Surg (2013) 0.77
Multivariate analysis of factors associated with smoking cessation in women. J La State Med Soc (2005) 0.77
Can inhibition of telomerase increase pancreatic cancer cell's susceptibility to chemotherapeutic reagents? Hepatobiliary Pancreat Dis Int (2002) 0.77
Comparison of microarray analysis of fine needle aspirates and tissue specimen in thyroid nodule diagnosis. Diagn Mol Pathol (2010) 0.77
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors. Ann Surg Oncol (2014) 0.77
The differentiation of benign and malignant thyroid nodules. Adv Surg (2005) 0.77
Expanding the indications for single-incision laparoscopic cholecystectomy to all patients with biliary disease: is it safe? Surg Laparosc Endosc Percutan Tech (2015) 0.77
Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database. Ann Surg (2012) 0.76
Tract recurrence of a follicular thyroid neoplasm following transaxillary endoscopic thyroidectomy. Thyroid (2012) 0.76
Gene expression profiling of thyroid tumors--clinical applicability. Nat Clin Pract Endocrinol Metab (2006) 0.76
Self-reported differences in daily raw vegetable intake by ethnicity in a breast screening program. J Natl Med Assoc (2002) 0.75
Isolated splenic metastasis from rectal carcinoma: a rare occurrence. Case Rep Oncol (2011) 0.75
Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications. Surg Endosc (2012) 0.75
Genomic medicine for cancer diagnosis. J Surg Oncol (2014) 0.75
Splenic cord capillary hemangioma and anemia: resolution after splenectomy. Am J Hematol (2006) 0.75
Hypopharyngeal rupture secondary to blunt trauma: presentation, evaluation, and management. J Trauma (2007) 0.75
Recurrent skeletal muscle and abdominopelvic low-grade leiomyosarcoma. Int J Gynaecol Obstet (2012) 0.75
Features Associated With Metastases Among Well-Differentiated Neuroendocrine (Carcinoid) Tumors of the Appendix: The Significance of Small Vessel Invasion in Addition to Size. Dis Colon Rectum (2015) 0.75
World wide what? The quality of information on parathyroid disease available on the Internet. Surgery (2009) 0.75
Expression of cyclooxygenase-2 in the periprosthetic capsule surrounding a silicone shell implant in the rat. Ann Plast Surg (2002) 0.75
The Department of Surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center: at the forefront of surgical innovation. Am Surg (2009) 0.75